Conveners
Session 7 - Nuclear Chemistry, Radionuclide Production, High-Power Targetry
- Boris Zhuikov (Institute for Nuclear Research of Russian Academy of Sciences, Russia)
- Mauro L. Bonardi (UNIMI and INFN - Milano, Italy)
Prof.
Syed M. Qaim
(Forschungszentrum Jülich, Germany)
19/09/2012, 08:00
Nuclear Chemistry, Radionuclide Production, High-Power Targetry
Invited Lecture
Nuclear data play a key role in the optimisation of production routes of medical radionuclides. In general, the production data of all commonly used diagnostic and therapeutic radionuclides are well known. The international activities to standardise those data will be reviewed. Furthermore, some recent efforts to develop alternative routes of production of a few widely used radionuclides, such...
Prof.
Alex hermanne
(Cyclotron lab, Vrije Universiteit Brussel, Belgium)
19/09/2012, 08:30
Nuclear Chemistry, Radionuclide Production, High-Power Targetry
Invited Lecture
A. Hermanne1, R. Adam-Rebeles1, P. Van den Winkel1, L. De Vis1, R. Waegeneer1, F. Tarkanyi2, S. Takacs2, M.P. Takacs3.
1 Cyclotron Laboratory, Vrije Universiteit Brussel (VUB), Belgium.
2 Institute of Nuclear Research of the Hungarian Academy of Sciences (Atomki), Debrecen,...
Prof.
Susanta Lahiri
(Saha Institute of Nuclear Physics, India)
19/09/2012, 08:50
Nuclear Chemistry, Radionuclide Production, High-Power Targetry
Invited Lecture
`In last two decades our research group is involved in the heavy ion assisted production and separation of neutron deficient no-carrier-added radionuclides. The advantage of heavy ion assisted production is choice of wide range of projectiles and therefore increasing the possibilities of reaching desired radionuclide far from the stability line. The main disadvantage is low production cross...
Prof.
John C Clark
(University of Edinburgh, UK)
19/09/2012, 09:10
Radiopharmaceutical chemistry, radiodiagnostics, radiotherapy, theragnostics
Invited Lecture
Positron Emission Tomography (PET) Imaging requires radiolabelled materials (biomarkers) incorporating radionuclides that decay by positron emission.
They are largely neutron deficient and are made with a charged particle accelerator usually a cyclotron.
The most important radionuclides are 18F, 11C, 15O and 13N although an increasing interest is being seen in the radio metals in particular...
Dr
Renata Mikolajczak
(NCBJ Radioisotope Centre POLATOM, Poland)
19/09/2012, 09:30
Nuclear Chemistry, Radionuclide Production, High-Power Targetry
Invited Lecture
Radioisotope Centre POLATOM is a state owned laboratory in the structure of the National Centre for Nuclear Research. POLATOM develops techniques for practical application of radioisotopes in various sectors, among them majority of products and services used in health care. POLATOM is supporting domestic and international users in highly specialized radiopharmaceuticals and radiochemicals for...
Dr
Cathy Cutler
(University of Missouri, USA)
19/09/2012, 09:50
Nuclear Chemistry, Radionuclide Production, High-Power Targetry
Invited Lecture
The University of Missouri Research Reactor Center (MURR) was instrumental in the development of two commercialized radiotherapeutic agents: Sm-153 [Quadramet] for the palliation of pain due to metastatic bone cancer, and Y-90 labeled glass microspheres [Therasphere] for the treatment of liver cancer. MURR is now actively developing other radionuclides with potential for use as targeted...
Dr
Rostislav Kuznetsov
(Research Institute of Atomic Reactors, Russia)
19/09/2012, 10:10
Nuclear Chemistry, Radionuclide Production, High-Power Targetry
Invited Lecture
Production of Mo-99 was established in Russia more than 20 years ago. First facilities were placed at the Institute of Physics and Power Engineering and Karpov Physico-Chemistry Research Institute (both in Obninsk city). They were focused on domestic supply and had limited production capacity. The IPPE facility was shut-down a few years ago. The Karpov Insititute’ facility continues its...
Mr
Ali YOUNES
(SUBATECH laboratory (UMR 6457), Nantes 44307, France)
19/09/2012, 10:30
Nuclear Chemistry, Radionuclide Production, High-Power Targetry
Oral Communications
A new method is proposed for the production and purification of polonium-210 (Po-210). This method is based on the bombardment of a bismuth-209 (Bi-209) target with a 38 MeV alpha particle beam that conducts to the production of astatine-210 (8.1 hrs) which decays to Po-210. It is further purified from bismuth target by a wet method using a liquid –liquid extraction process with tributyl...
